S. The Flowflex COVID-19 Antigen Home Test does not differentiate between SARSCoV and SARS-CoV-2. Negative results do not rule out SARS-CoV2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.

com The Flowflex COVID-19 Antigen Home Test is a lateral flow chromatographic immunoassay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection. Negative results do not rule out SARS-CoV2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. For more information on EUAs please visit: https://www.

Negative results do not rule out SARS-CoV2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner. Negative results are presumptive, and confirmation with a molecular assay, if necessary for patient management, may be performed. FlowFlex COVID-19 Home Test, Each This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.